TAE Life Sciences
  • Our Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Advisors
    • News
    • Events
    • Careers
  • BNCT
    • History
    • How it Works
    • Benefits of BNCT
    • BNCT Virtual Clinic
  • Pipeline
  • Technology
  • Contact Us
  • TAE.com
  • NEW EBOOK
  • Our Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Advisors
    • News
    • Events
    • Careers
  • BNCT
    • History
    • How it Works
    • Benefits of BNCT
    • BNCT Virtual Clinic
  • Pipeline
  • Technology
  • Contact Us
  • TAE.com
  • NEW EBOOK

Developing-targeted-drugs-for-boron-neutron-capture-therapy-to-treat-refractory-cancers

Home > Developing targeted drugs for boron neutron capture therapy to treat refractory cancers > Developing-targeted-drugs-for-boron-neutron-capture-therapy-to-treat-refractory-cancers
February 21, 2022

Previous StoryDeveloping targeted drugs for boron neutron capture therapy to treat refractory cancers

Sign up for our latest news and information

* indicates required




TAE Life Sciences, 35 Parker, Irvine, CA 92618

* The TAE Life Sciences device and drugs are in development and not available for sale or commercial use

Copyright ©2023 TAE Life Sciences. All Rights Reserved. Privacy Policy